Skip to main content
OpenTrials
Completed

NCT Number: NCT01284764

Efficacy Study of a Low Volume of Water Intake and Mosapride for Endoscopy in Patients With Subtotal Gastrectomy

A low volume of water intake and mosapride will effectively reduce food residue in remnant stomach for patients who had undergone subtotal gastrectomy due to gastric cancer.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Foreign Body Left During Endoscopic Examination Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Neoplasms Neoplasms by Site Stomach Diseases Stomach Neoplasms

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Haeundae Paik Hospital, Inje University School of Medicine

Busan, 612-030, South Korea

About this study

We evaluate that a 500mL of water intake and mosapride will effectively reduce food residue in remnant stomach for patients who had undergone subtotal gastrectomy due to gastric cancer. We plan to compare this method with routine midnight fasting method for endoscopy in patients with subtotal gastrectomy.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Outpatients who had subtotal gastrectomy for gastric cancer

Exclusion criteria

  • Pregnancy
  • Lactation
  • History of anastomotic stricture
  • Recurrent advanced gastric cancer
  • Poor general condition( > 2 ECOG)
  • Other disseminated malignancy
  • Significant renal failure or congestive heart failure (CHF)
  • Liver failure

Treatment and study plan

Mosapride

Drug

Mosapride 10mg, one dosage, once evening of the day before the endoscopy

Other names: Gasmotin

Primary outcomes

  1. Degrees of food residue using endoscopic scoring system

    Time frame: six months

    We plan to evaluate how much a low volume of water and mosapride, compared with routine fasting, reduse food residue in gastric remnant for endoscopy.

Secondary outcomes

  1. Tolerability of a low volume of water and mosapride

    Time frame: six months

    We plan to evaluate tolerability of a low volume of water and mosapride compared with routine fasting for endoscopy preparation in patients with subtotal gastrectomy

Sponsors and collaborators

Lead sponsor

Inje University

Other

Registry information

Official study title

Efficacy of a Low Volume of Water Intake and Mosapride for Endoscopy Preparation in Gastric Cancer Patients With Subtotal Gastrectomy: A Randomized Controlled Trial

Acronym: SMW

Important dates

Study start
2011
Primary completion
2011
Study completion
2011
First posted
Jan 27, 2011
Registry last updated
Oct 5, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.